Disclosures for "Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis")
-
Dr. Frisaldi has received publishing royalties from a publication relating to health care.
-
Dr. Vollert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Casquar. Dr. Vollert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Embody Orthopedics . Dr. Vollert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals.
-
Husam Al Sultani has nothing to disclose.
-
Ms. Hafuth has nothing to disclose.
-
Prof. Benedetti has nothing to disclose.
-
Dr. Shaibani has nothing to disclose.